EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • April 11th, 2014 • rEVO Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
This LICENSE AGREEMENT (the “Agreement”), is made and effective as of March 31, 2014 (the “Effective Date”) by rEVO Biologics, Inc., a Massachusetts corporation with a business address at 175 Crossing Boulevard, Framingham, Massachusetts 01702 (“Licensee”) and, LFB USA, Inc., a Delaware corporation, having its principal place of business located at 175 Crossing Boulevard, Framingham, Massachusetts 01702 (“LFB USA”) each of LFB USA and Licensee being a “Party,” and collectively, the “Parties”).
ATRYN AGREEMENTAtryn Agreement • April 11th, 2014 • rEVO Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS AGREEMENT (this “Agreement”) is effective as of March 31, 2014 (the “Effective Date”), by and between rEVO Biologics, Inc., a Massachusetts corporation, having its principal place of business located at 175 Crossing Boulevard, Framingham, Massachusetts, 01702 (“rEVO”) and Laboratoire français du Fractionnement et des Biotechnologies, a French Corporation, having its principal place of business located at 3 avenue des Tropiques - ZA de Courtaboeuf, 91940 (“LFB” and together with rEVO, the “Parties” and each a “Party”).
ROFN AGREEMENTRofn Agreement • April 11th, 2014 • rEVO Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS AGREEMENT (this “Agreement”) is effective as of March 31, 2014 (the “Effective Date”), by and between rEVO Biologics, Inc., a Massachusetts corporation, having its principal place of business located at 175 Crossing Boulevard, Framingham, Massachusetts, 01702 (“rEVO”) and Laboratoire français du Fractionnement et des Biotechnologies, a French Corporation, having its principal place of business located at 3 avenue des Tropiques - ZA de Courtaboeuf, 91940 (“LFB” and together with rEVO the “Parties” and each a “Party”).
SUPPLY AGREEMENTSupply Agreement • April 11th, 2014 • rEVO Biologics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This SUPPLY AGREEMENT (“Agreement”) is made this 31st day of March 2014, between rEVO Biologics, Inc., a Massachusetts Corporation, having a principal place of business at 175 Crossing Boulevard, Framingham, MA 01702–USA (“rEVO”), and LFB USA, Inc., a Delaware corporation having a principal place of business at 175 Crossing Boulevard, Framingham, MA 01702–USA (hereinafter referred to as “LFB USA”). Each of rEVO and LFB USA may be referred to herein as a “Party” or, collectively, “Parties”.
